SEIZE YOUR GLORY

This Biotech Stock is Poised to Soar in 2025 Want in?

Read on to find out what Big Pharmaceuticals don't want you to know.

Isn't it about time to start treating people by releasing possible cures, cures that all of a sudden disappear as soon as we hear about them?

Bottom line- They have defrauded and scammed us of our health and our money. They lied to us. They used terrible intimidation tactics, in a downright abusive manner to squeeze out the smaller companies.

What They Do is Illegal and Subhuman!

In case you aren't aware, Big Pharmaceuticals exist so a select group of crooks, creeps, and downright nobodies can make a fortune off of YOU.

They force these medications down our throats, crap we probably don't need instead of trying to find a cure. Actually being human and allowing the cure to be released would be easy and too sensitive for them.

What a scam they have going! 

Well that's not 100% why we are here, is it. I like to rant sometimes, but it all ties in. We'll get to that later.

What You Need to Know About Biotechnology:

• Biology

• Agriculture

• Food Science

• Medicine

After a booming time for biotech during the early portion of the decade, as measured by the AMEX Biotech Index (BTK), the biotech sector of the market was shunned by investors for the larger portion of the 90's. From 1998-2000, a two year period, the BTK shot from 100 to 800. In other words, every $10,000 invested in BTK turned profits north of $80,000.

Wouldn't You Like to

be a Part of Profit Margins

Like This?

When the average man is asked the question, "What do you think of when you hear the word biotechnology?" The most common responses are, "breakthrough medicines" and "new cures."

Healthcare is 100%, the number one market for the biotech field in the United States, according to Bio.org. Before 2020, the United States will hit a RIDICULOUS $4.3 trillion dollars on biotechnology for healthcare.

Biotech companies have bought over 5,000 new medications to the market. The FDA approved over fifty new medications per month, versus the whopping thirty-seven approvals in 1999, just 10 years ago. The Fda is setting records in 2020 with approvals 

Is it Not Safe to Say That Biotech Investments are Far From Scarce?

Now all of you "savvy" investors who think you know it all and consider yourselves "professional chart readers," do yourselves a favor and don't even try it!

The first thing to understand, as investors, is although it may appear to be human nature to try and think positively and stay away from morbid thoughts... The fact remains, people are negative and they do get sick, people die, and hospitals are consistently packed. I'm sure you have waited for hours upon hours in an emergency room.

We, as Americans, thrive on dying comfortably. We are always brainstorming for new ways to make dying and illness more comfortable or ultimately disappear. I mean how many billions do we spend each year on trying not to look like we're dying?

FACT: The biotech sector of the markets are often viewed as a safe haven for your net worth; given that disease is inevitable in any economic climate, such investments may be referred to as recession proof.

With all of the money going into cures, medications and research and development, we're sure you must be asking yourself...

Where do I begin finding the BEST biotech investments?

A good rule of thumb is looking for companies that are researching areas such as cancer, AIDS, diabetes, neurological diseases, immunological diseases, viral infections and ESPECIALLY mental disorders.

Do You Really Know Anyone Who Isn't on Xanax or Valium Right Now?

How do you REALLY look for the right company?

Unfortunately, there are countless companies doing this type of research.

Look No Further!

I Have Found the Diamond in the Rough...

 The Silver Lining in That Gray Cloud...

 The Bees Knees...

 The Cats Pajamas...

Do You Follow Me?

The biotech sector is prepared for a huge year in 2020 During the current year, miniscule biotech companies have made a certain group of savvy investors filthy effin rich.  Were you involved? You should have been!

Various catalysts exist that most definitely boost stock or options prices, more importantly, through the roof:

• Rumors of a New Drug Being Released

• Actual Releases of Certain New Drugs

• Buyouts

• Approvals by the FDA

Why Have You Not Cashed In?

They Have a Cure!

 Word on the Street... Take Over!

Now I'm not talking about something I overheard at lunch at Cipriani's or Peter Luger's Steakhouse. This isn't something I read on a blog or heard on a podcast. This could potentially be a life changer for you, if you're on the right side.

Medarex (MEDX) are you familiar? If you follow the market you should!

Third week in July our clients were given a buy recommendation for the August 9 calls sitting at $.80. Clients diligent enough to not only hold on but cost average down when the options hit $.30, saw that 3 weeks later, there was a rumor of them being bought out by Bristol-Meyers Squibb. ON THAT NEWS, Their stock went from $8 to$16. Of greater magnitude, those $.30 options topped out at $7.20.

2300%!

You Know What It Feels Like to Hit for 2300%?

Allow Me to Show You!

Feels like every other trade we do. The fact of the matter is this wasn't my 1st, 2nd, or 3rd quadruple digit winner. Think about it for a second. Your probably living in some small town that raises cows, grows corn, you may not even have to lock your doors. Honestly, where are you getting your market information? Not to be blunt, but we eat, shit, and sleep Wall Street. This is all we know.

Happy Birthday!

I am giving you a gift, a gift so huge in capability, you're going to end up sending me gifts like the rest of my clients do. Is it my "2020 Biotech Recession Cure?" Of course, I'm going to give you that.

More importantly, you're going to one of Liquid traders on the other end of the line, acting as your watchdog at the firm, keeping you abreast of "spectacular" looking situations when they come around.

Communication is key. Unlike any other newsletter, you will have the "10" spoon feeding you some of the sexiest looking trading ideas Wall Street has ever had to offer. Just like I have to keep in close contact with my deal team, syndicate members, and let's just say some very influential figures on "The Street," our lines of communication must be wide open. It wouldn't be beneficial to you if they weren't.

You don't want to miss what could be a trading idea with a phenomenal intrinsic value that ends up being a high triple digit winner, do you?

Don't be that guy who misses out on a MEDX caliber position because you couldn't get in touch with me.

This is Urgent!

My Biotech Heavy-Hitter is Being Released in

ONE WEEK!

So, this is what it boils down to. If you give me one chance to prove we are for real, I guarantee you will be a client for life. It's been proven time and time again. I will show you winners you've only dreamt of. Normally, LIquid Stock Trader's Genome Newsletter Service is a very modest $5000 for the entire year. Right now , for the next 30 hungry clients looking to hit the next level and start receiving more serious caliber trades with higher intrinsic values, we will allow you to take a seat in this VIP service for half the price: $2500. Just imagine how much that $2500 investment will be worth when you find out I only speak the truth.

For $2500 we are going to give you this priceless recommendation verbally, telling you the exact recommended time to buy and the exact recommended moment to sell. This recommendation alone would be worth theinvestment, but that is no where near all you are receiving:

• One full year of our LIquid Stock Trade's Genome Newsletter.

• Several trades a week emailed to you through your LIquid Stock Trader's Genome service, including buy and sell alerts- in real time.

• When you sign in, you will be able to create an exclusive username and password allowing you to make full use of the "Members Only" section of our site.

• Most significantly, you will be working hand in hand with an actual Liquid Daily Trader. What other newsletter allows you to call in during market hours and work one on one with a remarkably talented, in the know trader on Wall Street?  None! 

The beauty of all of this is... A performance based business.

We are not fueled by commissions like a broker. If a fluke occurs and we only show you only losers, is it safe to say we will never hear from you again? On the flipside, when I show you a bunch of winners, are you going to want to know what we are doing next, and after that, and after that?

The $2500 will be the best investment you ever made.

The bottom line is that I will not stop making money, regardless of whether you are a client or not. My "2020 Biotech Recession Cure" will do what it is supposed to do with or without you.

• The Stock Trader's Genome will continue to put out winning recommendations. Liquid

Daily and its clients will continue to prosper.

So, in essence, do I need you as a client? Obviously not.

• But I want, respect and definitely VALUE your business. On the other hand, do you need myself and Liquid 

Daily on your side? Absolutely!

Don't let a paltry administration fee of $2500 hinder you from doing what you intended to do when you started trading, making mammoth amounts of money.

I'm sure you can live with information from some of the best, most talented traders and analysts on Wall Street.

We will take you there!

We live amazing live's and so should you!

"Damn Right I Like The Life I Live, Cause I Went From Negative to Positive!" -Christopher Wallace

You Will Too, If You Want it Badly Enough!

Don't miss out - STOP the losing!

2020 will be YOUR year!

P.S. As a bonus, Marcus Nikos , our top trader and majority owner, will be sliding a trade into the Stock Trader's Genome that is only going out to our Inner Circle clients. You do not want to miss out on this once in a lifetime opportunity.

SEIZE YOUR GLORY